Koa Shoji Holdings Co.,Ltd. (9273.T)

JPY 611.0

(2.0%)

Long Term Debt Summary of Koa Shoji Holdings Co.,Ltd.

  • Koa Shoji Holdings Co.,Ltd.'s latest annual long term debt in 2023 was 1.59 Billion JPY , down -18.02% from previous year.
  • Koa Shoji Holdings Co.,Ltd.'s latest quarterly long term debt in 2023 FY was 1.59 Billion JPY , down -18.02% from previous quarter.
  • Koa Shoji Holdings Co.,Ltd. reported annual long term debt of 1.94 Billion JPY in 2022, down -15.27% from previous year.
  • Koa Shoji Holdings Co.,Ltd. reported annual long term debt of 2.29 Billion JPY in 2021, down -13.25% from previous year.
  • Koa Shoji Holdings Co.,Ltd. reported quarterly long term debt of 1.59 Billion JPY for 2023 FY, down -18.02% from previous quarter.
  • Koa Shoji Holdings Co.,Ltd. reported quarterly long term debt of 1.76 Billion JPY for 2023 Q2, down -5.51% from previous quarter.

Annual Long Term Debt Chart of Koa Shoji Holdings Co.,Ltd. (2023 - 2015)

Historical Annual Long Term Debt of Koa Shoji Holdings Co.,Ltd. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 1.59 Billion JPY -18.02%
2022 1.94 Billion JPY -15.27%
2021 2.29 Billion JPY -13.25%
2020 2.64 Billion JPY -12.67%
2019 3.02 Billion JPY -9.6%
2018 3.34 Billion JPY -8.07%
2017 3.63 Billion JPY -3.04%
2016 3.75 Billion JPY 2151.93%
2015 166.67 Million JPY 0.0%

Peer Long Term Debt Comparison of Koa Shoji Holdings Co.,Ltd.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY -29.276%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.964%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 98.807%
Shionogi & Co., Ltd. 8.75 Billion JPY 81.819%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY -38.141%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 98.819%
Morishita Jintan Co., Ltd. 106 Million JPY -1401.306%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -1993.926%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 77.334%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 88.074%
Tsumura & Co. 54.37 Billion JPY 97.073%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -7133.564%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.159%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 86.654%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 79.967%
KYORIN Holdings, Inc. 435 Million JPY -265.835%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 41.941%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 65.916%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -5794.015%
Modalis Therapeutics Corporation 412.5 Million JPY -285.79%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 64.675%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 97.619%
Cyfuse Biomedical K.K. 345 Million JPY -361.271%
Toho Holdings Co., Ltd. 28.16 Billion JPY 94.35%